Detection Technology OyOMXHEX: DETEC

Business review January–March 2026 presentation

· Issued by Detection Technology Oy

‌Q1 Business review

January-March 2026

President and CEO Hannu Martola | 23 April 2026



‌Q1 2026

25.3

net sales, €m (22.2)

13.5

net sales change-% (-2.0)

2.4

EBITA, €m (1.4)

9.3

EBITA-% (6.3)

2 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Q1: Growth in all business applications and markets

Total net sales grew at a double-digit rate

Industrial sales +24%

  • Sales of line scan solutions grew strongly across all regions, primarily driven by the food industry

  • The growth in TFT sales continued

    Medical sales +16%

    • Growth driven by CT applications, particularly in APAC

      Security sales +5%

    • Sales increased in EMEIA and Americas

    • The EMEIA growth supported by security CT and cargo inspection, and the Americas by aviation line scan solutions

    • In APAC, market and sales declined

3 23.4.2026 Detection Technology | Business review January-March 2026 presentation





‌Net sales by quarter

(EUR 1,000)

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Q4

2023 2024 2025

Q1

2026

35,000

30,000

25,000

20,000

13.5

15,000

(YOY change-%)

10,000

5,000

0

4 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Operating margin (EBITA) excluding NRI

(EUR 1,000)

6.5%

6.3%

5.4%

7.0%

9.0%

9.3%

11.4%

10.0%

12.7%

12.4%

14.8%

15.3%

16.3%

6,000 25%

5,000

20%

4,000

3,000

15%

10%

2,000

5%

1,000

Q123

Q223

Q323

Q423

Q124

Q224

Q324

Q424

Q125

Q225

Q325

Q425

Q126

0 0%

EBITA excluding NRI (EUR 1,000) EBITA-% excluding NRI Mid-term EBITA-target 15%

5 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Q1 2026 sales split by regional business units

4.6%

25.9%

25.3

€m

TOTAL NET SALES

69.6%

NET SALES €m

YOY CHANGE-%

AMERICAS

1.2

32.7

APAC

17.6

10.1

EMEIA

6.5

20.7

6 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Q1 2026 sales split by main applications

18.4%

32.0%

25.3

€m

TOTAL NET SALES

49.7%

NET SALES €m

YOY CHANGE-%

INDUSTRIAL

4.6

23.5

MEDICAL

12.6

15.9

SECURITY

8.1

5.3

7 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Key figures

Q1 2026

Q1 2025

FY 2025

Net sales, EUR 1,000

25,264

22,249

101,023

Change in net sales, %

13.5%

-2.0%

-6.0%

EBITA, EUR 1,000

2,351

1,399

9,255

EBITA, %

9.3%

6.3%

9.2%

R&D costs, EUR 1,000

2,773

2,634

11,266

R&D costs, % of net sales

11.0%

11.8%

11.2%

Cash flow from operating activities, EUR 1,000

-3,418

1,425

3,885

Investments, EUR 1,000

409

390

2,965

Return on net assets (RONA, 12-month rolling), %

23.0%

33.9%

20.4%

Earnings per share, EUR

0.13

0.05

0.44

8 23.4.2026 Detection Technology | Business review January-March 2026 presentation



‌Strategic levers

BASE

Continue to do what we do, better

TFT

Drive TFT flat panel growth, across regions and markets

ADDED VALUE

Commercialize more value-added integrated HW-SW solutions to a broader customer base

NEW TECH

Seek new opportunities beyond current scope (Photon counting & SW)

Being the most trusted partner that drives customer success through exceptional usability

Elevate performance culture

9 23.4.2026 Detection Technology | Business review January-March 2026 presentation



ADDED VALUE

‌AIDA commercialized and the first deliveries completed

  • Scalable detector platforms with integrated software

  • Algorithms & AI enhance image quality and enable low-dose, high-quality 3D imaging

  • Integrated architecture enables to develop new data-generating solutions for further added value

  • Meeting market demand as big OEMs shifting to photon counting, new entrants need value-added solutions

10 17/3/2026 Detection Technology | DNB Carnegie small cap technology seminar



‌X-ACE HS

BASE



Launched AIDA compatible, off-the-shelf CT detector family for high-speed and low-dose medical

imaging

11 23.4.2026 Detection Technology | Business review January-March 2026 presentation





‌Sales expectation Q2 and Q3 2026

Industrial

to decline in Q2

Medical

to grow in Q2

Security

to grow in Q2

Q2 sales are expected to grow in all regions: APAC, EMEIA, and the Americas

YOY total net sales to grow in Q2 and Q3 2026

12 23.4.2026 Detection Technology | Business review January-March 2026 presentation

‌Business outlook

Detection Technology expects total net sales to grow year-on-year in Q2 and Q3 2026.

The geopolitical situation, new U.S. import tariffs, and price competition especially in China create uncertainty.

13 23.4.2026 Detection Technology | Business review January-March 2026 presentation



MEDIUM TERM

Annual sales growth

>10%

MEDIUM TERM

Operating margin (EBITA)

15%

ANNUAL

Dividend

30-60%

‌FINANCIAL TARGETS

14 23.4.2026 Detection Technology | Business review January-March 2026 presentation



https://www.deetee.com



Earlier from Detection Technology Oy

All Detection Technology Oy news releases